Full Name
James Ryan
Job Title
Chief Legal Officer and Chief Business Officer
Company
BioNTech
Speaker Bio
James Ryan has guided BioNTech through a wide range of key business, IP and transactional activities, mergers and acquisitions, strategic collaborations and equity capital markets transactions including the Company’s IPO in 2019. James Ryan and his teams played a pivotal role in the
successful development of the Pfizer-BioNTech COVID-19 Vaccine, supporting every legal aspect of the programme, its launch and commercialisation, and was also instrumental in the strategic collaboration with Bristol Myers Squibb.
James Ryan joined BioNTech in 2018 as General Counsel and Senior Vice President Legal & IP and was appointed as a Member of the Management Board in 2023. He brings nearly 20 years of global legal and IP expertise in the pharmaceutical industry to the Company. In his
prior role, he established the legal group of GW Pharmaceuticals (NASDAQ: GWPH), where he also served as Head of Legal Affairs. James Ryan also worked for a number of UK and US law firms, including Special Counsel at Covington & Burling LLP, where he specialised in
commercial and strategic transactions with a focus on companies in the life sciences sector.James Ryan has a Ph.D. in epigenetics from the University of St Andrews, is a member of the Law Society of England & Wales, and a member of the Law Society of Ireland.
successful development of the Pfizer-BioNTech COVID-19 Vaccine, supporting every legal aspect of the programme, its launch and commercialisation, and was also instrumental in the strategic collaboration with Bristol Myers Squibb.
James Ryan joined BioNTech in 2018 as General Counsel and Senior Vice President Legal & IP and was appointed as a Member of the Management Board in 2023. He brings nearly 20 years of global legal and IP expertise in the pharmaceutical industry to the Company. In his
prior role, he established the legal group of GW Pharmaceuticals (NASDAQ: GWPH), where he also served as Head of Legal Affairs. James Ryan also worked for a number of UK and US law firms, including Special Counsel at Covington & Burling LLP, where he specialised in
commercial and strategic transactions with a focus on companies in the life sciences sector.James Ryan has a Ph.D. in epigenetics from the University of St Andrews, is a member of the Law Society of England & Wales, and a member of the Law Society of Ireland.
Speaking At
